Medicamen Organics IPO opens for subscription on June 21, 2024 and closes on June 25, 2024. Is investing in this IPO worth your money or is it better to avoid it? In this Medicamen Organics IPO review video we will answer this question for you, covering points like company's financials, competitive strength, business experience and clientele and more! Subscribe to Planify if you find our Medicamen Organics IPO analysis video informative!
About Medicamen Organics Limited:
Medicamen Organics is a pharmaceutical company in India with over 30 years of experience in the industry. Established in 1995, they specialize in manufacturing a wide range of medication forms including tablets, capsules, liquids, and ointments. Their two WHO-GMP certified plants in Haridwar ensure adherence to strict quality standards.
Additional Medicamen Organics IPO Details:
Medicamen Organics IPO price band is set at βΉ32 to βΉ34 per share. The minimum lot size for an application is 4000 Shares. The minimum amount of investment required by retail investors is βΉ136,000. The minimum lot size investment for HNI is 2 lots (8,000 shares) amounting to βΉ272,000.
Join Us For all the latest updates about startups, preipo and unicorns.
Keep yourself updated with the market situation.
Join us on Facebookβ
LinkedINβ
Twitterβ
Instagramβ
Telegramβ
Contact us at +91 7065560002 via Whatsapp/Normal call
Or Mail us at help@planify.in
β¬οΈ Download the app for easy access. Links are given below:
βPlanify iPhone Appβ
Stay Connected, Stay Informed β
Donβt miss out on exclusive updates, market trends, and real-time investment opportunities. Be the first to know about the latest unlisted stocks, IPO announcements, and curated Fact Sheets, delivered straight to your WhatsApp.